CardieX

CardieX

Medicine

Company website

About

CardieX is an Australian medical company specializing in cardiovascular diseases. It develops devices for monitoring heart and vascular function.

Based in Sydney, CardieX is a developer of cardiovascular health monitoring devices. The company's flagship product SphygmoCor XCEL is used for blood pressure monitoring.

This is a secondary listing of the company, whose shares are already trading on the Australian Stock Exchange. Through the IPO, CardieX plans to raise $10 million for further development.
___________________________________
Number of employees:
25-50 employees
___________________________________
Headquarters:
55 Lime Street, Suite 301 Sydney, New South Wales, 2000 Australia


2022 © All rights reserved

You can always come to our office to discuss any questions with our manager

Dubai

Sharjah Media City, Sharjah, UAE

USA

500 Delaware ave,
STE 1 #1960 Wilmington, DE, USA

Czech Republic

Czech Republic, Prague, Bilkova 855/19

The investment opportunities posted on this website's Pre-IPO section are private placements of securities that are not traded on the open market, subject to the ownership period requirements, and intended for investors who do not require liquid investments. Investments in private companies may be considered speculative, involving high risk, including the significant loss of investment risk. Investors must be able to afford to lose all their investments.